Here are five things to know.
1. Study participants will include pregnant women infected with HIV only, Zika virus only and concurrent infections with HIV and Zika. Researchers will also enroll women not infected with either virus.
2. Researchers are working to enroll participants in Puerto Rico and will later recruit expectant mothers in Brazil and the continental United States.
3. Infants will be monitored for a year following their birth.
4. The initial phase of the study will involve about 200 pregnant women. If the study is successful, researchers will enroll 1,800 additional participants.
5. The study is slated to last 4 to 6 years.
More articles on infection control:
Minnesota health officials anticipate end of measles outbreak
Flesh-eating bacteria infects 3 in Alabama county
Top 10 infection control stories, July 3-7
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.